Pubrica


Clinical and Experimental Otorhinolaryngology (Clin Exp Otorhinolaryngol, CEO) is an international, peer-reviewed journal that publishes high-quality articles on recent advances in otorhinolaryngology head and neck surgery. The journal is dedicated to advancing patient care in disorders of the ear, nose, throat, head, and neck.

Clinical and Experimental Otorhinolaryngology

Aim and Scope

Clinical and Experimental Otorhinolaryngology (Clin Exp Otorhinolaryngol, CEO) is an international, peer-reviewed journal that publishes high-quality articles on recent advances in otorhinolaryngology head and neck surgery. The journal is dedicated to advancing patient care in disorders of the ear, nose, throat, head, and neck.

The CEO publishes original research articles, clinical trials, and review articles covering both clinical and basic science research across the full spectrum of otorhinolaryngology head and neck surgery. All manuscripts containing research data undergo rigorous peer review. Submitted manuscripts must not have been previously published or be under consideration for publication elsewhere. Founded in 2008, the CEO is published in English quarterly (February, May, August, and November) by the Korean Society of Otorhinolaryngology Head and Neck Surgery. The journal aims to disseminate scientifically rigorous, evidence-based research from diverse subspecialties within the field.

All articles published in Clinical and Experimental Otorhinolaryngology are open access and distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Clinical and Experimental Otorhinolaryngology Journal

Clinical and Experimental Otorhinolaryngology

Impact-Factor

Impact Factor

3.4

SJR-SCImago-Journal-Rank

SJR (SCImago Journal Rank)

0.91 (Q1)

CiteScore

CiteScore

5.6,

Frequency

Frequency

Quarterly

Submission-to-Acceptance

Publisher

Korean Society of Otorhinolaryngology-Head and Neck Surgery

Acceptance-Rate

Acceptance Rate

Not mentioned

Key Highlights

5 Year Impact Factor

2.9

H Index

41

Indexing

SCIE: Science Citation Index Expanded, PubMed/PubMed Central (PMC), Scopus, Journal Citation Reports (JCR), DOAJ Directory of Open Access Journals. Other: Korea Citation Index (KCI), Korea Med, Google Scholar

Initial Editorial Decision

1–3 weeks.

First Post Review Decision

6–12 weeks.

Submission to Acceptance

68–88 days

Acceptance to Publication

25–27 days.

Publication Type

open-access journal

Open Access Model

The CEO is fully open access, meaning articles are freely available online immediately upon publication.

Article Processing Charges (APC)

$1,000 USD

Main Text

3000 Words

Abstract

limited to 250 words.

References

Maximum of 30 references

Tables/Figures

8 figures/tables,